Immage Biotherapeutics Corp. filed its 10-K on Nov 04, 2015 for the period ending Aug 31, 2015. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+5.92% | 105B | |
-4.43% | 64.68B | |
+60.48% | 43.21B | |
+16.73% | 39.33B | |
+6.77% | 32.99B | |
+12.31% | 20.09B | |
+13.41% | 17.05B | |
+25.44% | 15.96B | |
+5.80% | 14.69B |
- Stock Market
- Equities
- IMMG Stock
- News Immage Biotherapeutics Corp.
- Immage Biotherapeutics Corp. Auditor Raises 'Going Concern' Doubt